@JasonHouMD

Crohn’s and Colitis Specialist in Houston Tx at Baylor and the Houston VA.

Joined April 2020
  • Tweets234
  • Following228
  • Followers633
86Media
🩺 BCM Gastroenterology & Hepatology 2026 Board Review Course 📅 Oct 3–4, 2026 📍 Baylor St. Luke's Medical Center, Houston, TX 💻 In-person + Virtual Register: cpd.education.bcm.edu/conten…… #GITwitter #MedEd #GIBoards
1
8
34
2,662
Join us for the 25th Annual GI & Hepatology Conference @bcmhouston 🗓️March 28–29, 2026 📍 Houston, TX Join experts discussing: 🔹 AI in GI 🔹 Endoscopic suturing 🔹 Intestinal ultrasound in IBD 🔹 Barrett’s esophagus 🔹 Obesity & metabolic GI 🔹 Pancreatic Diseases @BCMCME
Wasif Abidi, MD, PhD@WasAbiDocMar 3
📣Honored to direct the 25th Annual GI & Hepatology Conference < 1 Mo away ⏰ Cutting edge GI, practice-changing updates, and network with our local and visiting experts! Or just come for the food 🥮🧁 Register & Agenda👉 tinyurl.com/ettjbf6a @WasAbiDoc @JDBernicaMD
5
1
19
3,724
#JaredSninsky kicking off the Houston @CrohnsColitisFn MyIBD Learning Patient Conference with IBD 101 talk @BCMDeptMedicine @bcm_gihep
2
5
645
Just published @JCC_IBD! ECCO Consensus on Dietary Management of IBD: includes recommendations on diet therapies for disease management, nutrition optimization, and IBD prevention. academic.oup.com/ecco-jcc/ad…
36
2
76
5,220
#CGH4ALL @AGA_CGH 📣 As we look for more targets in therapy of UC, this study reports on an IL-22 Agonist that did not have efficacy when compared to placebo or Vedo! 🔗 cghjournal.org/article/S1542… Reported by @Ansari_Zaid7 @ibd_pal @EdBarnesMD @IBDGastroDocSg @Bealoquebea @KatieFalloonMD @CarlKayMD @JCC_IBD @laura_tee_mdgi @PashaShabanaMD @JanssenUS @DrHArmstrong
9
25
1,628
🙏Very honored and excited for this great opportunity 🤩 cannot wait to work with this team and contribute to the GI field. @BCMCME @bcm_gihep @bcmhouston @ACGCRJ @AmCollegeGastro #GITwitter #MedEd
ACGCRJ@ACGCRJ7 Jul 2025
Replying to @ACGCRJ @DaniyalAbbasMD @DushDahiya
Welcome, 2025-2026 ACG Case Reports Journal Associate Editors! #GIfellows @hassamalii @KAlsabb @Ansari_Zaid7 @AasthaBharwad @Chatterjee_MD @umer446 @fouadsjaber @AbelJosephMD @RahulKarnaMD @FaisalNimri3 @SanjeevaniTomar
2
3
43
2,570
Congratulations @shifaumarMD and @DeptVetAffairs
Shifa Umar, MD@shifaumarMD5 Jul 2025
Milestone for Veteran care🎖️ @VAHouston becomes the first VA Pancreas Center of Excellence in 🇺🇸 Proud moment for #VeteransHealth 👏 ow.ly/JBCN50Wf6iL Grateful for the support & leadership @EndoscopyOthman @ruben_hernaez @SeragHashem @KanwalFasiha @BiykemB #HappyJuly4th🎆
2
5
28
2,706
Replying to @MondayNightIBD @DCharabaty @abbvie @JanssenUS @TakedaPharma @sabpeds @JosephHabibi_MD @ibdtweets @andrewbgrossman @DignassAxel @BettenworthDb @fgomollon @berkeleydoc @dunleavy_katie @halesj126
40M with ileocolonic #Crohns in clinical remission on UST, endo healing on last CLN 2 yrs ago. He says he feels fine. 🧪labs: Hb 10 g/dl, Ferritin 60 ng/ml #MondayNightIBD What would you at that visit?
12%Reassurance, monitor Hb
16%Start PO iron
20%✅PROMIS fatigue survey
51%📆Colonoscopy +/- EGD
88 votes • Final results
1
12
1
12
3,276
Big thanks to @DrScottDLee @PedsIBD_Wahbeh and #DonaldLum for the warm invite, and fun engaging program last weekend with @IBDHorizons in Portland!
This Post is from an account that no longer exists. Learn more
1
6
2,481
#Anemia is more than a Hb number, it affects #IBD pts QOL & outcomes 🗳️PreB2B Polls 🧵#Back2Basics @AimenKhanMD @AroojMianMD May 12 📌Convo @JasonHouMD May 19 🆓#CME👉🏽 bit.ly/MNIBD24-25 Support by educ grants @abbvie @JanssenUS @TakedaPharma 📌Where r you in your🩺?
38%IBD Specialist
23%General GI/ CRSurgery
33%Trainee, Fellow
5%PharmD, RD, APP, RN,
78 votes • Final results
2
16
3
29
6,667
I just boosted my IBD knowledge in today's by sitting near #krish_subramanian @bcm_gihep course – at Houston, TX
1
2
10
879
Did you know @KanwalFasiha’s attending was @ibddocmaria? 😮 Or that @brownbrij76 is an amusement park enthusiast? 🎢 We had a great time getting to know our newest board members today! Thank you to each of them for sharing about their work and interests.
American Gastroenterological Association (AGA)@AmerGastroAssn7 Apr 2025
We're thrilled to have our new governing board members @KanwalFasiha, @RickPeekMD, Drs. Michael Kochman, Russ Arjal, and @brownbrij76 at AGA's offices today! Let's give them a warm welcome 👋🏽 as they begin their new roles in AGA leadership!
1
4
21
3,023
📢 Join us for the 24th Annual BCM GI & Liver Course! This event brings together experts, sharing latest innovations & advances in gastroenterology & liver disease. Open to physicians, NPs, PAs, nurses, fellows & trainees. Don't miss out! Register Here: cpd.education.bcm.edu/conten…
3
9
4
17
12,340
Novel MoA Lusvertikimab IL-7 inhibitor for ulcerative colitis presented #ECCO2025 - Phase 2 RCT - Improved MMS over placebo @ 10wk - HEMI improvement in 32% @ 10wk (🔼 25% over placebo)
2
6
369
RESCUE- Prospective RCT of pts w/ secondary failure to ustekinumab in Crohn’s #ECCO2025 ⭐️ IV UST reinduction: 4 wk vs. 8 wk UST ⭐️ NO difference @ 48wk ⭐️ Both groups- Steroid free clinical remission <20% @ 48wk Limited value of pushing for q4wk UST ➡️ switch MOA?
1
4
236
Applaud @EliLillyandCo for studying complexity of urgency in #ulcerativecolitis #Miri #ECCO2025 ⭐️ Interesting only weak to moderate correlation between the 3 different aspects of urgency ⭐️ Urgency is often the most isolating sx of UC, important for us to better understand
Jason Hou@JasonHouMD23 Feb 2025
Prof Danese presenting LUCENT-URGE data #ECCO2025 - Open Label wk12 analysis or mirikizumab for #ulcerativecolitis - Looked at 3 new scales for urgency ⭐️ BU - severity ⭐️ BUF- frequency ⭐️ SDT- stool deferral time - All scales improved on Miri @ 12wk
1
272
Prof Danese presenting LUCENT-URGE data #ECCO2025 - Open Label wk12 analysis or mirikizumab for #ulcerativecolitis - Looked at 3 new scales for urgency ⭐️ BU - severity ⭐️ BUF- frequency ⭐️ SDT- stool deferral time - All scales improved on Miri @ 12wk
1
1
2
445
GRAVITI SubQ induction of Guselkumab #ECCO2025 - Phase 3 GUS for Crohn’s - 12wk Clin Remission 🔼35% over plac - 12wk Endo response 🔼20% over plac - 48wk Clin Rem 🔼~39% over plac - 48wk Endo Res 🔼~38% over plac ⭐️Similar 12 and 48 wk data compared to IV induction
1
2
256
- SOR102: Novel oral dual acting local biologic Phase 1B study for UC - Fast potential onset of action in higher dose arm - Interesting PK- only detectable in serum in 1 pt - 6/12 pts developed anti-drug antibody? Low titer- clinical impact unclear #ECCO2025
Jason Hou@JasonHouMD23 Feb 2025
Replying to @vipuljairath
@vipuljairath presenting #ECCO2025 Novel oral dual acting biologic for #ulcerativecolitis - Phase 1B (6 pt placebo/16 pt on tx) - Oral, local acting(?) dual TNFa/IL23 inhibitor - Primary outcome= safety- No major signals - Exploratory clinical outcome- positive signal
1
2
324
Prof Reinisch presented companion RELIEVE UCCD- UC Induction #ECCO2025 - #Duvakitug TL1A Phase 2B - Primary outcome Clinical remission wk14 - 🔼 27% over placebo - Similar 🔼 bio experienced/naive - ?High placebo clinical response -52% vs. 81%/70% tx @sanofi @tevapharm
Jason Hou@JasonHouMD23 Feb 2025
Replying to @vipuljairath
@vipuljairath presented RELIEVE UCCD #ECCO2025 - Novel TL1A inhibitor #Duvakitug - Phase 2B CD induction - Primary outcome wk 14 Endoscopic response - 🔼35% over placebo @ higher dose - ? High placebo clinical remission: 41% vs. 54% high dose @sanofi @tevapharm
1
4
435
Load more